Press release July 2022

A new page is turning for Texcell and its holding companies Soparbiotech and Soparbiotech International.

The founder Bernard Plichon leaves his positions as Chairman and CEO of Soparbiotech and Chairman of Soparbiotech International. He is replaced by Céline Saint Olive Baque, 44 years old. Céline graduated from ESPCI-Paris with 2 master’s degrees in Physics and Bioengineering. She started her career in medical imaging research laboratories at Philips in Germany and IBM in San Jose, then joined L’Oréal in their capillary research laboratories in Paris then Shanghai. In 2012, she joined a family office in Eindhoven specialized in early-stage investments for healthcare startups. This is how she met Noraker, of which she has been CEO since 2015.

Céline will be seconded as CEO of Soparbiotech International by Eric Henriet, 53 years old. Eric graduated from Ecole Polytechnique and a doctor in Chemistry. He will also serve as Chairman and CEO of Texcell SA. Eric started his career in the pharmaceutical industry (Rhône Poulenc Rorer, Aventis, Sanofi, Merck) and then was in charge of public-private partnerships for the major Paris- Saclay project. He then helped a very small company linked to the pharmacy business to scale-up. Before joining Texcell, he was COO of Adare Biome.

The shareholders, management and employees would like to thank Bernard Plichon for all his achievements, his energy and his talent which have made Texcell a world-class company recognized for its expertise in virology, immunology and cell culture.